Consider an experiment, in which a new drug is tested for the first time on human subjects, namely healthy volunteers. Such experiments are often performed as dose-escalation studies: a set of increasing doses is preselected; individuals are grouped into cohorts; and in each cohort, dose number i can be administered only if dose number $$i-1$$ i - 1 has already been tested in the previous cohort. If an adverse effect of a dose is observed, the experiment is stopped, and thus, no subjects are exposed to higher doses. In this paper, we assume that the response is affected both by the dose or placebo effects and by the cohort effects. We provide optimal approximate designs for estimating the effects of the drug doses compared with the placebo with respect to selected optimality criteria (E-, MV- and LV-optimality). In particular, we prove the optimality of the so-called Senn designs with respect to all of the studied optimality criteria, and we provide optimal extensions of these designs for selected criteria.
TEST – Springer Journals
Published: Mar 7, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera